T CELL RESPONSE TO A PERIODONTAL PATHOGEN
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
批准号:
6350608
负责人:
ELLEN KRAIG
金额:
$21.52万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-15 至 2003-01-31
关键词:
Actinobacillus actinomycetemcomitans B lymphocyte T cell receptor T lymphocyte antibody bacteria infection mechanism bacterial antigens bacterial genetics bacterial proteins cytokine disease /disorder model enzyme linked immunosorbent assay genetic library human tissue humoral immunity hybridomas laboratory mouse leukocyte activation /transformation oral bacteria periodontitis polymerase chain reaction recombinant proteins tissue /cell culture transfection /expression vector western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have focused on the periodontal pathogen, Actinobacillus actinomycetemcomitans (Aa). Individuals infected with this bacterium generate a specific humoral immune responses; some of the antigens recognized by serum antibodies have already been identified. On the other hand, the T cell epitopes on Aa have not yet been defined. Towards this end, we have undertaken an innovative, T cell hybridoma-based approach in order to dissect the T cell responses to Aa. In preliminary mice were orally inoculated with live bacteria and a panel of T cell hybridomas was generated. To our surprise, approximately 50% of the T cells reactive with Aa were specific for leukotoxin, a virulence factor produced by this oral pathogen. In order to characterize the immune response to Aa further, we now propose to: Aim 1. Clone genes that encode other T cell epitopes by direct screening of an Aa genomic library. The identities of the Aa proteins recognized by the T cell hybridomas will be determined and recombinant peptides generated for use in Aims 2 and 3. Aim 2: Characterize the nature of the immune response in vivo to individual Aa antigens. Mice will be: a) immunized with purified recombinant peptides, b) immunized with bacteria, or c) orally inoculated with viable Aa. Immune activation to individual T cell epitopes will then be assessed by studies of antibody production, T cell activation and cytokine production (Th1 versus Th2), and protection in a murine inflammation model. Aim 3. Determine whether the predominant T cell antigens in mice are similarly stimulatory in Aa-infected patients. Specifically, peripheral blood lymphocytes from EOP patients will be cultured in vitro with individual recombinant Aa peptides and T cell stimulation assessed by cytokine production and by spectrotyping. These aims will: i) provide the first evidence regarding T cell antigenic epitopes on this pathogen and ii) assess the relationship between T cell epitopes that are immunodominant in mice and those seen in humans. The long term goal is to develop and validate a model for evaluating host-parasite interactions, vaccine potency, and immune protection for periodontal diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maternal nutrient restriction: Effects on offspring immune function
-
批准号:8433316
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2012
-
负责人:ELLEN KRAIG
-
依托单位:
Maternal nutrient restriction: Effects on offspring immune function
-
批准号:8284123
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2012
-
负责人:ELLEN KRAIG
-
依托单位:
EFFECTS OF AGING ON VACCINE EFFICACY IN NONHUMAN PRIMATE MODELS
-
批准号:8357689
-
项目类别:
-
资助金额:$16.47万
-
财政年份:2011
-
负责人:ELLEN KRAIG
-
依托单位:
EFFECTS OF AGING ON VACCINE EFFICACY IN NONHUMAN PRIMATE MODELS
-
批准号:8172716
-
项目类别:
-
资助金额:$7.14万
-
财政年份:2010
-
负责人:ELLEN KRAIG
-
依托单位:
THE EFFECTS OF AGING IN NONHUMAN PRIMATES
-
批准号:8172690
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2010
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:8055013
-
项目类别:
-
资助金额:$55.03万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7907218
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
THE EFFECTS OF AGING IN NONHUMAN PRIMATES
-
批准号:7957946
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7653192
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7781318
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
USE OF RECALL IMMUNITY TO ENHANCE VACCINE EFFICACY IN THE ELDERLY
-
批准号:7349836
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2006
-
负责人:ELLEN KRAIG
-
依托单位:
USE OF RECALL IMMUNITY TO ENHANCE VACCINE EFFICACY IN THE ELDERLY
-
批准号:7165398
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2005
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:6824520
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:6886809
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:7228617
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:7058323
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:6150549
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:2766716
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:6498068
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
AGING AND AUTOIMMUNE MYASTHENIA GRAVIS
-
批准号:2002461
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:ELLEN KRAIG
-
依托单位:
海外基金